A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obinutuzumab or Placebo in Combination with Mycophenolate Mofetil in Patients with Active Class III or IV Lupus Nephritis

被引：0
|
作者：
Furie, Richard [1 ]
Aroca, Gustavo [2 ,3 ]
Alvarez, Analia [4 ]
Fragoso-Loyo, Hilda [5 ]
Zuta Santillan, Elizabeth [6 ]
Rovin, Brad [7 ]
Schindler, Thomas [8 ]
Hassan, Imran [9 ]
Cascino, Matthew [10 ]
Garg, Jay P. [11 ]
Malvar, Ana [12 ]
机构：
[1] Northwell Hlth, Great Neck, NY USA
[2] Simon Bolivar Univ, Barranquilla, Colombia
[3] Clin Costa, Barranquilla, Colombia
[4] CEMIC, Buenos Aires, DF, Argentina
[5] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico
[6] Inst Ginecol & Reprod, Lima, Peru
[7] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[8] F Hoffmann La Roche & Cie AG, Basel, Switzerland
[9] Hoffmann La Roche Ltd, Mississauga, ON, Canada
[10] Genentech Inc, San Francisco, CA USA
[11] Genentech Inc, San Francisco, CA 94080 USA
[12] Hosp Fernandez, Org Maed Invest, Buenos Aires, DF, Argentina
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0939
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
    Cuffari, Carmen
    Spalding, William
    Achenbach, Heinrich
    Thakur, Manoj
    Gabriel, Andre
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
  • [32] EFFICACY AND SAFETY OF QUETIAPINE FOR DELIRIUM IN ICU PATIENTS:A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Devlin, John W.
    Roberts, Russel
    Fong, Jeffrey J.
    Skrobik, Yoanna
    Harvey, Johanne
    Riker, Richard
    Robbins, Tracey
    Hill, Nicholas
    Garpestad, Erik
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A17 - A17
  • [33] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
    Rovin, Brad H.
    Teng, Y. K. Onno
    Ginzler, Ellen M.
    Arriens, Cristina
    Caster, Dawn J.
    Romero-Diaz, Juanita
    Gibson, Keisha
    Kaplan, Joshua
    Lisk, Laura
    Navarra, Sandra
    Parikh, Samir V.
    Randhawa, Simrat
    Solomons, Neil
    Huizinga, Robert B.
    LANCET, 2021, 397 (10289): : 2070 - 2080
  • [34] A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, ST
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Thadani, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 254A - 254A
  • [35] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis
    Guntupalli, Kalpalatha
    Dean, Nathan
    Morris, Peter E.
    Bandi, Venkata
    Margolis, Benjamin
    Rivers, Emanuel
    Levy, Mitchell
    Lodato, Robert F.
    Ismail, Preeti M.
    Reese, Amber
    Schaumberg, John P.
    Malik, Rajesh
    Dellinger, R. Phillip
    CRITICAL CARE MEDICINE, 2013, 41 (03) : 706 - 716
  • [36] Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
    Khanna, Puja P.
    Khanna, Dinesh
    Cutter, Gary
    Foster, Jeff
    Melnick, Joshua
    Jaafar, Sara
    Biggers, Stephanie
    Rahman, A. K. M. Fazlur
    Kuo, Hui-Chien
    Feese, Michelle
    Kivitz, Alan
    King, Charles
    Shergy, William
    Kent, Jeff
    Peloso, Paul M.
    Danila, Maria I.
    Saag, Kenneth G.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (08) : 1523 - 1532
  • [37] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
    Papp, K
    Mease, P
    Garovoy, M
    Zhang, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
  • [38] A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
    Wallace, Daniel J.
    Stohl, William
    Furie, Richard A.
    Lisse, Jeffrey R.
    McKay, James D.
    Merrill, Joan T.
    Petri, Michelle A.
    Ginzler, Ellen M.
    Chatham, W. Winn
    McCune, W. Joseph
    Fernandez, Vivian
    Chevrier, Marc R.
    Zhong, Z. John
    Freimuth, William W.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1168 - 1178
  • [39] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease
    Yokoyama, Shunichi
    Yoshinaga, Takuma
    Matsuzaki, Juntaro
    Suzuki, Hidekazu
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (04) : 1187 - 1199
  • [40] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
12345